| Status: AWMSG assessment in progress | |
For the emergency treatment of allergic reactions (anaphylaxis), and idiopathic or exercise induced anaphylaxis, in adults and children weighing 30kg or more |
|
Medicine details |
|
| Medicine name | Intranasal adrenaline (EURneffy) |
| Formulation | 2 mg in 100 microlitres nasal spray, solution in single-dose container |
| Reference number | 6284 |
| Indication | As above |
| Company | ALK Abello |
| BNF chapter | Respiratory system |
| Assessment type | Limited |
| Status | AWMSG assessment in progress |
| Scrutiny Panel meeting date | 05/03/2026 |
| LOWMAG meeting date | 01/07/2026 |
| AWMSG meeting date | 09/09/2026 |